Stockreport

Cybin Reports Second Quarter Fiscal Year 2026 Financial Results and Recent Business Highlights [Yahoo! Finance]

Cybin Inc. Common Shares  (CYBN) 
PDF - On track to report topline data from Phase 2 study evaluating CYB004 for the treatment of Generalized Anxiety Disorder ("GAD") in Q1 2026 - Continues to advance Pha [Read more]